Yahoo
NasdaqCM - BOATS Real Time Price USD

Cellectar Biosciences, Inc. (CLRB)

1.2500 +0.1000 (+8.70%)
At close: November 6 at 4:00:01 PM EST
1.2500 0.0000 (0.00%)
Overnight: 8:02:05 PM EST
CLRB Q3 2026 earnings call
November 10, 2026 at 8:30 AM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Assets
14,978.3210 25,474.0470 12,075.5800 21,589.7900
Total Liabilities
6,441.1570 11,179.3660 27,234.5480 13,436.5460
Total Equity
8,537.1640 14,294.6810 -15,158.9680 8,153.2440
Balance Sheet, Supplemental
Operating Lease Obligation Maturity Schedule Total
410 494.0030 552.9820 604
Total Debt
409.5860 494.0030 552.9820 603.8280
Net Debt
-12,786.4470 -22,794.6040 -9,012.0060 -19,262.5300
Working Capital
9,288.7280 14,862.5150 -14,905.3090 9,028.0590
Invested Capital
8,946.7500 14,788.6840 -14,605.9860 8,757.0720
Tangible Book Value
8,537.1640 14,294.6810 -15,158.9680 8,153.2440
Common Equity Book Value
8,016.3860 13,773.9030 -19,836.6000 8,153.2440
12/31/2022 - 11/10/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: